RxNorm Names
SILACE
(docusate sodium)
syrup
[Silarx Pharmaceuticals,Inc]
Permanent Link:
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5bd29e4d-ea87-4436-9dc9-624c7f7c1561| Category | DEA Schedule | Marketing Status |
|---|---|---|
| HUMAN OTC DRUG LABEL | OTC monograph not final |
NOTE:MOST OTC DRUGS ARE NOT REVIEWED AND APPROVED BY FDA, HOWEVER THEY MAY BE MARKETED IF THEY COMPLY WITH APPLICABLE REGULATIONS AND POLICIES. FDA HAS NOT EVALUATED WHETHER THIS PRODUCT COMPLIES.
Uses
- for gentle, reliable relief from occasional constipation (irregularity)
- generally produces bowel movement in 12 to 72 hours
Warnings
- Do not use
-
laxative products for longer than 1 week unless told to do so by a doctor
- Do not use if you are presently taking mineral oil unless told to do by a doctor
Ask a doctor before use if you have
- stomach pain
- nausea
- vomiting
- noticed a sudden change in bowel habits that last over two weeks
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
- take as directed by a doctor
- doses must be given in a 6-8 oz glass of milk or fruit juice, to prevent throat irritation
- dose may be taken as a single daily dose or in divided doses
- dosage should be adjusted to individual response
| Adults and children 12 years of age and older | 1 to 6 tablespoonfuls, or as directed by a doctor |
| Children 6 to under 12 years of age | 1 to 2 1/2 tablespoonfuls, or as directed by a doctor |
| Children under 6 years | Ask a doctor |
Other information
- store at room temperature 20°-25°C (68°-77°F)
- protect from freezing and excessive heat
- do not use if tamper-evident safety seal around cap is broken or missing
-
dispense in tight, light-resistant container with a child-resistant closure
| SILACE
docusate sodium syrup |
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Labeler - Silarx Pharmaceuticals,Inc (161630033) |
Revised: 12/2012
Document Id: 097dffa4-4dc2-4b41-b459-bb14f47e8502
Set id: 5bd29e4d-ea87-4436-9dc9-624c7f7c1561
Version: 10
Effective Time: 20121210
Silarx Pharmaceuticals,Inc
Review RxNorm Normal Forms